Table 1.
Summary of metabolomic studies of chronic hepatitis B
| Ref. | Year | Species | Tissue | Platform | Up-regulated | Down-regulated |
| Zhou et al[23] | 2012 | Human | Serum | LC-MS | Cortisol, GCA, GCDCA, LysoPC (15:0), LysoPE (22:6), C16:1-CN | Tryptophan, C10-CN, C10:1-CN, C8-CN, C6-CN |
| CHB 30 N 30 | ||||||
| CHB/N | ||||||
| Soga et al[24] | 2011 | Human | Serum | CE-TOM | γ-Glu-Thr | |
| CHB 7 N53 | LC-MS | |||||
| CHB/N |
CHB: Chronic hepatitis B; LC-MS: Liquid chromatography-mass spectrometry; GCA: Glycocholic acid; GCDCA: Glycochenodeoxycholic acid; LysoPC: Lysophosphatidylcholine; LysoPE: Lysophosphatidylethanolamine; CN: C16:1-acylcarnitine.